Does Cognex Stock Lead the Pack?
As of February 12, 2026, Cognex‘s (CGNX) stock has strongly outperformed its peers over the past year. However, a closer look at its high valuation within the industrial automation landscape reveals strong free cash flow and healthy revenue growth. Its operating margin, while respectable, doesn’t lead the pack, and an elevated PE ratio suggests a premium, potentially limiting upside compared to some more moderately valued competitors.
- CGNX’s 16.3% operating margin trails AME’s 26.2%, reflecting AME’s strategic focus on high-margin acquisitions and efficient cost management.
- CGNX’s 10.2% revenue growth outpaced most peers, driven by AI machine vision demand, yet lagged ROCK’s robust industrial automation.
- CGNX gained 50.8%, outperforming peers, with its 89.4 PE signaling high investor expectations for AI-driven machine vision growth.
Here’s how Cognex stacks up across size, valuation, and profitability versus key peers.
| CGNX | ROCK | TDY | ZBRA | AME | EMR | |
|---|---|---|---|---|---|---|
| Market Cap ($ Bil) | 9.8 | 1.6 | 30.3 | 13.7 | 52.8 | 81.1 |
| Revenue ($ Bil) | 1.0 | 1.4 | 6.0 | 5.4 | 7.2 | 18.2 |
| PE Ratio | 89.4 | 375.3 | 37.1 | 32.8 | 35.9 | 35.1 |
| LTM Revenue Growth | 10.2% | 21.8% | 7.4% | 8.3% | 3.7% | 3.6% |
| LTM Operating Margin | 16.3% | 10.2% | 18.5% | 14.8% | 26.2% | 19.9% |
| LTM FCF Margin | 22.0% | 7.4% | 17.3% | 15.4% | 22.9% | 14.2% |
| 12M Market Return | 50.8% | -8.7% | 27.7% | -22.3% | 24.1% | 18.0% |
For more details on Cognex, read Buy or Sell CGNX Stock. Below we compare CGNX’s growth, margin, and valuation with peers across years
Revenue Growth Comparison
- Does Alphabet Stock Still Have Room to Run?
- How Advanced Micro Devices Stock Gained 90%
- How To Earn 13% Yield While Waiting to Buy APH 30% Cheaper
- Cash Machine Trading Cheap – Adobe Stock Set to Run?
- Walmart Stock Hands $76 Bil Back – Worth a Look?
- UnitedHealth Stock Shares $77 Bil Success With Investors
| LTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| CGNX | 10.2% | – | 9.2% | -16.8% | -3.0% |
| ROCK | 21.8% | – | -5.0% | -0.9% | 3.7% |
| TDY | 7.4% | – | 0.6% | 3.2% | 18.3% |
| ZBRA | 8.3% | 8.3% | 8.7% | -20.7% | |
| AME | 3.7% | – | 5.2% | 7.3% | 10.9% |
| EMR | 3.6% | 3.0% | 15.3% | 9.9% |
Operating Margin Comparison
| LTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| CGNX | 16.3% | – | 12.6% | 14.7% | 26.7% |
| ROCK | 10.2% | – | 11.8% | 11.2% | 9.4% |
| TDY | 18.5% | – | 18.4% | 18.4% | 17.8% |
| ZBRA | 14.8% | 14.8% | 15.4% | 12.8% | |
| AME | 26.2% | – | 25.6% | 25.9% | 24.4% |
| EMR | 19.9% | 19.6% | 15.2% | 18.2% |
PE Ratio Comparison
| LTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| CGNX | 89.4 | – | 58.1 | 54.5 | 33.6 |
| ROCK | 375.3 | – | 11.0 | 16.3 | 30.8 |
| TDY | 37.1 | – | 29.3 | 24.7 | 26.5 |
| ZBRA | 32.8 | 29.5 | 37.7 | 47.4 | |
| AME | 35.9 | – | 34.5 | 31.6 | 32.7 |
| EMR | 35.1 | 32.6 | 36.0 | 4.2 |
Still not sure about CGNX stock? Consider portfolio approach.
The Asset Allocation Edge For Managing Large Accounts
The best advisors focus on allocation, not just selection. A proven multi-asset framework helps you optimize client portfolios for both growth and protection.
Scale your practice without compromising on quality. Our wealth management partner provides advisors with institutional-grade asset allocation models that have withstood major market stress tests. This framework, which includes the Trefis High Quality Portfolio, allows you to deliver sophisticated investment solutions to your entire client base efficiently.